Zenyatta Ventures Ltd.; Motion for Injunction by First Nation community adjourned to May 11.

Zenyatta Ventures Ltd. (ZEN : TSX Venture) (“Zenyatta” or “Company”) announces that the Motion for Injunction by Constance Lake First Nation (“CLFN”) in Ontario Superior Court on Friday April 29 is adjourned until Wednesday May 11. In the meantime, the Judge has ordered that CLFN, Zenyatta and Ontario (“Crown”) carry on further consultation while drilling continues on the current claim blocks. Prior to commencing its drill program, Zenyatta had been engaged in consultative discussions and dialogue with CLFN for over a year regarding its planned exploration activities. The Company also delayed its winter drill program for numerous weeks while those discussions continued, with the objective of reaching a Memorandum of Understanding (“MOU”) with CLFN. Zenyatta has been very proactive and cooperative during the consultation process and felt that we had developed a very respectful and trusting relationship with CLFN leadership. In fact, in mid-February, the Company felt it had already reached an agreement on a MOU with the Chief and Council. CLFN is seeking injunctive and other relief against the Company and Crown regarding Zenyatta's current exploration activities and the Mining Act from Ontario Superior Court. Among other things, CLFN alleges that the defendants have failed to adequately consult and accommodate them in connection with Zenyatta’s current mineral exploration activities. Zenyatta is undertaking a 20,000 metre drill program at the Albany Project near Hearst, Ontario. The Albany Project is within the asserted traditional territory of CLFN. Zenyatta remains committed to on-going good faith dialogue with the Crown and CLFN respecting the community's concerns but will defend its rights and interests. The Company’s Board and management are focused and committed to mineral exploration in Northern Ontario and have always accepted responsibility for developing and maintaining strong community relations. To find out more on Zenyatta Ventures Ltd., please visit our website at www.zenyatta.ca or contact the Company at info@zenyatta.ca or Tel. 807-346-1660. This news release may contain forward-looking statements and is subject to a variety of risks and uncertainties that could cause actual events or results to differ materially from those projected in the Company’s forward-looking statements and expectations. The forward-looking information contained herein is given as of the date hereof and the Company assumes no responsibility to update or revise such information to reflect new events or circumstances, except as required by law. The TSX Venture Exchange does not accept responsibility for the adequacy or accuracy of this release
  • Share

About Zentek Ltd.

Zentek is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection and treatment. Zentek is currently focused on commercializing ZenGUARD™, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases. The company also has an exclusive agreement to be the global commercializing partner for a newly developed, highly scalable, aptamer-based rapid pathogen detection technology.

To find out more about Zentek Ltd., please visit our website at www.zentek.com. A copy of this news release and all material documents in respect of the Company may be obtained on Zentek's SEDAR profile at www.sedar.com.

Forward-Looking Statements

This news release contains forward-looking statements. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. Although Zentek believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information, which only applies as of the date of this news release, and no assurance can be given that such events will occur in the disclosed time frames or at all. Zentek disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, other than as required by law. Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

For further information:

Tyler Dunn

Director, Marketing & Communications

tdunn@zentek.com

Subscribe for Updates

Interested in recieving press releases directly to your inbox? Subscribe to Zentek's mailing list for all the latest news.